Solyco Capital

Global Gaming League is a professional gaming entertainment organization that operates an online platform offering video game tournaments and events for a global audience of all ages. It aims to provide an unrivaled entertainment experience, modeled after the structure, professionalism, and competitiveness of the NFL.

SkyMirr, founded in 2021 and based in Satellite Beach, Florida, specializes in innovative radio frequency (RF) technology for various applications, including broadband wireless communication and medical equipment. The company develops advanced RF technology products aimed at enhancing human life by improving the effectiveness of medical treatments for serious diseases. Additionally, SkyMirr's telecommunications solutions enable clients to deliver cost-effective and high-performance broadband wireless services to consumers. Through its commitment to advancing RF technology, SkyMirr seeks to make significant contributions to both healthcare and communication sectors.

FluidLogic specializes in high-performance active hydration systems. Their vehicle-mounted products enable users to maintain optimal hydration levels, particularly in demanding environments like motorsports. They offer the FluidLogic Flush 360 Assembly and WAVE systems, along with accessories such as helmet kits. The company aims to empower individuals to thrive through hydration innovation.

AthleteAgent.com is a digital platform facilitating connections between businesses and professional athletes or teams for endorsement deals. It offers comprehensive, verified information about athletes' agents, contracts, business ventures, endorsements, philanthropy, and team front office details.

Toralgen, Inc. is a preclinical stage biopharmaceutical company based in Indianapolis, Indiana, focused on the development and commercialization of innovative human therapeutics. Established in 2017, the company specializes in a unique drug delivery technology platform that utilizes polybile nanopill delivery systems. This technology is designed to enhance the oral administration of active drug compounds, ensuring targeted delivery to specific sites within the body. By addressing the challenges associated with oral drug delivery, Toralgen's nanopills aim to improve the efficacy and safety of therapeutic agents, ultimately enhancing patient outcomes in healthcare.

Toralgen, Inc. is a preclinical stage biopharmaceutical company based in Indianapolis, Indiana, focused on the development and commercialization of innovative human therapeutics. Established in 2017, the company specializes in a unique drug delivery technology platform that utilizes polybile nanopill delivery systems. This technology is designed to enhance the oral administration of active drug compounds, ensuring targeted delivery to specific sites within the body. By addressing the challenges associated with oral drug delivery, Toralgen's nanopills aim to improve the efficacy and safety of therapeutic agents, ultimately enhancing patient outcomes in healthcare.